Veranstaltungen

BioM WebSeminar: International Market Access Series - Go Japan

Japan is the world’s 3rd largest healthcare market and ranks amongst Europe’s top 5 pharmaceutical trading partners. With an unprecedented combination of increased longevity and declining birth rates, the Japanese market offers significant opportunities for innovative life science companies, novel technologies, services and products and can be a gateway to other Asian markets.

 

Time and Place
Thursday, 01.10.2020, 9:30 am – 11:30 am
Digitally delivered (GoToWebinar®)

Content
Japan is the world’s 3rd largest healthcare market and ranks amongst Europe’s top 5 pharmaceutical trading partners. With an unprecedented combination of increased longevity and declining birth rates, the Japanese market offers significant opportunities for innovative life science companies, novel technologies, services and products and can be a gateway to other Asian markets.

Get an insight into:

  • the Japanese market, the authorities and other players in Japan
  • the admission requirements and responsibilities
  • options to find good and loyal local business partners and more …

Target Group
This WebSeminar is intended for staff from Business Development, International Sales, Export APAC and Regulatory Affairs.


Speakers/Abstracts

Dr. Hitoshi Kuboniwa - Corporate Advisor at Chugai / Steering Committee Chairman of Japan Bioindustries Association
Dr. Kuboniwa was awarded both a Ph.D. and MS in Polymer Chemistry from the Tokyo Institute of Technology in Japan. He has lectured extensively at pharmaceutical conferences and acted as a keynote speaker at the Bio Japan Trade Show and the American Biomanufacturing Summit in San Francisco. His areas of speciality include: biotechnology and future of biotechnology in Japan, global harmonization initiatives,  Japan’s policy agenda and Biotech Frontier. He is also very active with Japan as the leading BioEconomy in 2030, in Bioindustry’s infrastructure and in the role of biotechnology in politics and industry trends. Dr. Kuboniwa is also a high-level expert in bio-industrial topics as big data, biosimilars and bioproduction.

The Japanese perspective: differences and similarities. Kuboniwa san will give you an insight into the Japanese market and its players (PMDA, METI, JBA, government, etc.), the role of biotechnology as Japan's national strategy (what is it and what does it mean) and the goal of becoming the world's leading bio-economy by 2030 and what this means from a pragmatic point of view. Furthermore, legal and regulatory differences will be shown (tax officials, a superhighway for regenerative medicine etc.).

Stefan Sandström - Manifestum
Stefan Sandström is an emigrated Swede and has lived in Japan for 14 years. Stefan has a strong background in chemical engineering and medicine. He is business coach for companies within the Nordic Innovation House network and an incubator linked to the University of Umeå. Sweden. He is not only a RKW accredited business consultant (i.e. German companies that hire him only have to pay 50% of the investment) but also an investor and board member of several companies. His network in Japan includes some of the major bio-clusters, the major biopharma companies and industry organizations. He has already successfully supported several companies last year in the context of the Start.Smart.Global training project developed by BioM  (funded by EIT Health).

About Manifestum
Manifestum is a Sweden based business consultancy with its major work being performed in Japan, linking the European Biopharma Industry to Japan and vice versa. Most common types of projects include setting up distribution,  finding clients and setting up strategic partnerships. Manifestum works with trusted partners and their collective skills enable a wide range of support for projects in Japan.
The presentation will provide insight into the role and function of management consulting in entering the Japanese market. You will get an introduction to the unique business culture of Japan and what it means to be European in this country. The speaker will also share his expert knowledge on: expected timetables for doing business in Japan, why it is important to do your homework, different entry strategies and examples on how others enter Japan.

Ms. Chizuko Minami - Chief senior staff at Life Sciences Industry Division, Osaka Prefectural Government - Osaka Bio Headquarters

Ms. Minami is organising business matching events between European and local companies in Osaka, e.g. the Biotech & Pharma Virtual Partnering Conference. This global partnering event takes place annually in October and is co-organised by Osaka Bio Headquarters and the EU-Japan Centre. This year, the conference is organised virtually on 28 - 30 September. Ms. Minami will report on the conference and the work of Osaka Bio Headquarters to support the cooperation between Japan and Europe.

About Osaka Bio Headquarters
In order to promote the further development of the life sciences industry in Osaka Prefecture, a prefectural industry-academia-government collaboration paved the way for a headquarters system called “Osaka Bio Headquarters.” The headquarters system is a system composed of the “Osaka Bio Strategy Promotion Conference," the heart of the system, and the “Osaka Prefecture Life Science Industry Division,” a bureau that is responsible for implementing the headquarter functions.

Dr. Thomas Bruckdorfer - CSO & VP Business Development, Iris Biotech GmbH
Dr. Bruckdorfer is a partner in Iris Biotech GmbH since 2002 and co-founder of Iris Biotech Laboratories GmbH. He has over 20 years of experience in international marketing, sales and distribution of fine chemicals and sophisticated chemical technologies. He holds a Ph.D. in chemistry and broadened his education by studying  “Management and Distribution of Complex Technical Projects and Systems”. He serves as CSO and VP Business Development and project manager for Russia, Korea, Japan, China, India and USA.

About Iris Biotech
Iris Biotech GmbH is a renowned, globally active company for innovation and know-how in the field of pharmaceuticals and biotechnology. Starting in 2001 with a small range of commodities for peptides, we meanwhile developed our portfolio to a unique list of standard reagents and unusual building blocks for various life science applications. With our custom synthesis service and our products in drug discovery, drug delivery, and diagnostics being available in laboratory quantities for the research sector up to multi ton scales distinguishes Iris Biotech GmbH as a globally and locally valued partner.


Program
The flyer and detailed agenda for the BioM-WebSeminar "International Market Access Series - Go Japan" can be downloaded (pdf). The WebSeminar will be held in English.

Registration
The seminar is free to attend but electronic registration is necessary.

Organisation
Dr. Andreas Berghammer and Anja Weber
BioM Biotech Cluster Development GmbH
E-mail: berghammer@remove-this.bio-m.org                    E-mail: weber@remove-this.bio-m.org
Phone: +49 (0) 89-899679-17                             Phone: +49 (0) 89-899679-35